US Neurology – Volume 15 Issue 2 – Fall 2019

Welcome to the fall edition of US Neurology. This edition features a diverse range of topical articles covering many therapeutic areas relevant to neurologists and other practitioners involved in the care of patients with neurological illness. We begin with an expert interview with Ruben Kuzniecky on the subject of the Human Epilepsy Project, which aims […]

Epilepsy is an important cause of disability and mortality, and affects around 50 million people worldwide.¹ Focal seizures, which originate in only one part of the brain, account for around 80% of all epileptic seizures.² Treating epilepsy, however, is challenging since the types, severity, frequency, and impact of unprovoked seizures vary from person to person. […]

Parkinson’s disease (PD) is a progressive neurodegenerative disorder, with an average age of onset of 56, that causes abnormalities both in motor and non-motor functioning. Clinical features that affect motor function include bradykinesia, rigidity, resting tremor, gait abnormality, and postural instability. Clinical features that affect non-motor function include cognitive dysfunction, depression, anxiety, sleep disorders, orthostatic […]

Headache is the second most common reason children seek neurological care in the USA.¹ Migraine can affect children of all ages, and by the age 10, it affects more than 5% of children in the USA.¹ Before puberty, it affects both boys and girls equally; however, post-puberty migraine is more prominent in females at a […]

Migraine prevention medication is recommended for: (1) frequent headaches (generally defined as at least four migraines per month that are associated with some degree of impairment); (2) migraines that significantly interfere with a patient’s daily activities despite acute treatment; (3) migraine with brainstem aura and hemiplegic migraine independent of frequency; (4) contraindication to, treatment failure […]

Multiple sclerosis (MS) involves inflammation, demyelination and neurodegeneration of the central nervous system (CNS) and is characterized by variable degrees of axonal loss and gliosis.¹ Lesions occur in both the white and grey matter. Generally, the overall incidence of MS and other chronic autoimmune disorders has increased in the last 100 years.² The incidence and […]

Parkinson’s disease (PD) is a multifaceted neurodegenerative disease that progressively affects individuals’ mobility. In addition to the cumulative motor disability, a plethora of non-motor symptoms (NMS-PD) can be encountered at different stages of the disease. Some of these NMS-PD are indeed regarded as significant determinants of the patient’s quality of life, functional independence, and overall […]

Spinal muscular atrophy (SMA) is a progressive neuromuscular disorder affecting approximately 1 in 10,000 births. It is characterized by predominantly proximal muscle weakness as a result of degeneration of anterior horn cells of the spinal cord.¹ In most patients with SMA, the disease is caused by a homozygous deletion or mutation of the telomeric survival […]